|
For purposes of this report, HAI includes hospitals, nursing homes, outpatient surgery centers and dialysis centers. The focus of this report is on selected devices, pharmaceuticals and environmental products currently used or under development for treatment of viral, bacterial and fungal infections. The global market for HAI products is estimated at between $12 billion and $17 billion in 2012 (depending on the products included in the study) with high single-digit growth through 2018. The North American market and in particular the U.S. holds the largest market share of any region at 45% to 50% and the fastest growing regions for HAI treatments are Brazil and the Asian region, particularly China and India. STUDY GOALS AND OBJECTIVES Healthcare-acquired infections are viral, bacterial or fungal infections that patients acquire after they are admitted to a healthcare facility. Patients can acquire these infections from routine care; surgery; or as a complication from the use of medical devices such as ventilators, catheters and intravenous lines. This report is designed to investigate the global HAI market by treatment area and by type of treatment, with supporting tables and figures to illustrate projected growth. Within each type of treatment, regional analyses will focus on the Americas (i.e., Canada, U.S., Mexico, Central America and South America); EMRA (i.e., Europe, the Middle East, Russia and Africa); and Asia (i.e., Japan, China, India, other Western Pacific countries such as Australia and New Zealand and other Southeast Asian countries). SCOPE AND FORMAT This report offers forecasts by treatment segment and type of treatment, from 2013 through 2018, including supporting analyses for projections. The main market segments are analyzed by pharmaceutical treatments, environmental treatments and infection control devices/products. This report is a valuable tool for anyone assessing the HAI market and attempting to devise a strategy to successfully compete in this market. This report provides background on the structure of the HAI market and the chief challenges and opportunities it faces. It offers the information needed to understand the current market and to address the emerging one. The report is an invaluable tool for business planners, acquisition specialists, licensing strategists, product managers, market research analysts, investing consultants and others interested in the HAI market, its products, its participants and its future. METHODOLOGIES AND INFORMATION SOURCES Information for this report was obtained from a variety of primary and secondary research sources, including industry analysts, annual reports and agencies and organizations such as the U.S. Securities and Exchange Commission (SEC), the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the U.S. National Institutes of Health (NIH), American Hospital Association (AHA), Infectious Disease Society of America (IDSA), American Society of Heating, Refrigerating and Air Conditioning Engineers (ASHRAE), National Institute of Allergy and Infectious Diseases (NIAID), the National Hospital Discharge Survey (NHDS) and government agencies outside the U.S. Secondary sources include literature searches, journal articles, product literature and press releases. REPORT HIGHLIGHTS This report provides: Forecasts of the markets for healthcare-acquired infection (HAI) devices, pharmaceuticals, and therapies by treatment segment and treatment type, including supporting analyses for projections Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018 Valuable tools for anyone assessing the HAI market and attempting to devise a strategy to successfully compete in the industry Background on the structure of the HAI market and the opportunities available as well as the chief challenges it faces Information needed to understand the current market and to address the emerging market Comprehensive company profiles of key players in the market. Table of contents : Chapter- 1: INTRODUCTION - Complimentary 3 $0 REASONS FOR DOING THE STUDY STUDY GOALS AND OBJECTIVES SCOPE AND FORMAT METHODOLOGIES AND INFORMATION SOURCES ANALYST CREDENTIALS RELATED BCC REPORTS BCC ONLINE SERVICES DISCLAIMER Chapter- 2: SUMMARY 3 $250 Table Summary : GLOBAL MARKET FOR SELECTED HAI TREATMENTS, THROUGH 2018 Figure Summary : GLOBAL MARKET SHARES OF HAI TREATMENTS BY GEOGRAPHICAL AREA, 2013 AND 2018 Chapter- 3: GLOBAL HAI OVERVIEW 28 $1070 RISKS FOR ACQUIRING HAI MOST COMMON HEALTHCARE-ASSOCIATED INFECTIONS GRAM-POSITIVE BACTERIA GRAM-NEGATIVE BACTERIA VIRAL INFECTIONS FUNGAL INFECTIONS PREVENTING HAI HEALTHCARE INFECTION POINTS OF GENERATION PROACTIVE TREATMENTS HUMAN AND MONETARY COSTS OF HAI CHINESE MARKET CHANGES IN THE INDUSTRY About Author Bio: I am working with a market research company which provides market research reports , custom research, company profiles, industry analysis, country reports , business reports, online databases and the report on Healthcare-acquired infections etc. Through our industry analysis you can identify opportunities, analyze the requirements of the customers and study the competition sector wise.
Related Articles -
Pharmacueticlas and healthcare, Healthcare-acquired infections,
|
